Novel Once-Weekly Basal Insulin Fc Achieved Similar Glycemic Control With a Safety Profile Comparable to Insulin Degludec in Patients With Type 1 Diabetes
Kazda, Christof M, Bue-Valleskey, Juliana M, Chien, Jenny, Zhang, Qianyi, Chigutsa, Emmanuel, Landschulz, William, Wullenweber, Paula, Haupt, Axel, Dahl, Dominik
Published in Diabetes care (01.05.2023)
Published in Diabetes care (01.05.2023)
Get full text
Journal Article
Once-Weekly Basal Insulin Fc Demonstrated Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With Type 2 Diabetes: A Phase 2 Randomized Control Trial
Bue-Valleskey, Juliana M, Kazda, Christof M, Ma, Chenchen, Chien, Jenny, Zhang, Qianyi, Chigutsa, Emmanuel, Landschulz, William, Haupt, Axel, Frias, Juan P
Published in Diabetes care (01.05.2023)
Published in Diabetes care (01.05.2023)
Get full text
Journal Article
Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies
Kazda, Christof M, Ding, Ying, Kelly, Ronan P, Garhyan, Parag, Shi, Chunxue, Lim, Chay Ngee, Fu, Haoda, Watson, David E, Lewin, Andrew J, Landschulz, William H, Deeg, Mark A, Moller, David E, Hardy, Thomas A
Published in Diabetes care (01.07.2016)
Published in Diabetes care (01.07.2016)
Get full text
Journal Article
811-P: Initiation of Once-Weekly (QW) Basal Insulin Fc (BIF) in Three Patient Populations in Phase 2 Studies Using a One-Time Loading Dose (LD) Minimizes Transient Hyperglycemia and Is Not Associated with Excess Hypoglycemia Risk vs. Degludec
BUE-VALLESKEY, JULIANA M., KAZDA, CHRISTOF M., ZHANG, QIANYI, HAUPT, AXEL, DAHL, DOMINIK, FRIAS, JUAN P.
Published in Diabetes (New York, N.Y.) (20.06.2023)
Published in Diabetes (New York, N.Y.) (20.06.2023)
Get full text
Journal Article
806-P: Once Weekly (QW) Basal Insulin Fc (BIF) and Daily Degludec (DEG) Achieve Comparable Glycemic Control in Three Patient Populations Studied during Phase 2—Clinical Insights from CGM Assessments
KAZDA, CHRISTOF M., BUE-VALLESKEY, JULIANA M., ZHANG, QIANYI, HAUPT, AXEL, FRIAS, JUAN P., DAHL, DOMINIK
Published in Diabetes (New York, N.Y.) (20.06.2023)
Published in Diabetes (New York, N.Y.) (20.06.2023)
Get full text
Journal Article
229-OR: Orforglipron Improves Markers of Beta-Cell Function and Insulin Sensitivity in Type 2 Diabetes
ROSENSTOCK, JULIO, ROBINS, DEBORAH A., DUFFIN, KEVIN L., WILSON, JONATHAN M., MATHER, KIEREN J., BANERJEE, HIYA, LIN, YANZHU, EYDE, SARAH, KAZDA, CHRISTOF M., KONIG, MANIGE
Published in Diabetes (New York, N.Y.) (14.06.2024)
Published in Diabetes (New York, N.Y.) (14.06.2024)
Get full text
Journal Article
192-OR: Glycemic Control with Once-Weekly Basal Insulin Fc (BIF) in Persons with Type 2 Diabetes Mellitus (T2DM) Using Continuous Glucose Monitoring (CGM) in a Phase 2 Study
KAZDA, CHRISTOF M., CHIEN, JENNY, ZHANG, QIANYI, CHIGUTSA, EMMANUEL, LANDSCHULZ, WILLIAM, WULLENWEBER, PAULA, HAUPT, AXEL, FRIAS, JUAN P.
Published in Diabetes (New York, N.Y.) (01.06.2021)
Published in Diabetes (New York, N.Y.) (01.06.2021)
Get full text
Journal Article
215-OR: Once Weekly (QW) Basal Insulin Fc (BIF) Demonstrated Similar Glycemic Control to Once Daily (QD) Insulin Degludec (DEG) in Insulin-Naïve Patients with Type 2 Diabetes (T2D)
BUE-VALLESKEY, JULIANA M., KAZDA, CHRISTOF M., MA, CHENCHEN, CHIEN, JENNY, ZHANG, QIANYI, CHIGUTSA, EMMANUEL, LANDSCHULZ, WILLIAM, SWAN, JENNIFER, HAUPT, AXEL, FRIAS, JUAN PABLO
Published in Diabetes (New York, N.Y.) (01.06.2022)
Published in Diabetes (New York, N.Y.) (01.06.2022)
Get full text
Journal Article
761-P: Effect of Orforglipron vs. Placebo and Dulaglutide on Glycemic Control and Body Weight in Patients with Type 2 Diabetes
FRIAS, JUAN P., HSIA, STANLEY H., EYDE, SARAH, LIU, RONG, MA, XIAOSU, KONIG, MANIGE, KAZDA, CHRISTOF M., PRATT, EDWARD J., MATHER, KIEREN J., HAUPT, AXEL, ROBINS, DEBORAH A.
Published in Diabetes (New York, N.Y.) (25.06.2023)
Published in Diabetes (New York, N.Y.) (25.06.2023)
Get full text
Journal Article
52-OR: Effect of Oral Nonpeptide GLP-1 Receptor Agonist Orforglipron (LY3502970) in Participants with Obesity or Overweight—A Phase 2 Study
WHARTON, SEAN, BLEVINS, THOMAS, CONNERY, LISA B., ROSENSTOCK, JULIO, RAHA, SOHINI, MATHER, KIEREN J., HAUPT, AXEL, ROBINS, DEBORAH A., PRATT, EDWARD J., KAZDA, CHRISTOF M., KONIG, MANIGE
Published in Diabetes (New York, N.Y.) (23.06.2023)
Published in Diabetes (New York, N.Y.) (23.06.2023)
Get full text
Journal Article
Treatment with the glucagon receptor antagonist LY2409021 increases ambulatory blood pressure in patients with type 2 diabetes
Kazda, Christof M., Frias, Juan, Foga, Irene, Cui, Xuewei, Guzman, Cristina B., Garhyan, Parag, Heilmann, Cory, Yang, Jihui Anne, Hardy, Thomas A.
Published in Diabetes, obesity & metabolism (01.08.2017)
Published in Diabetes, obesity & metabolism (01.08.2017)
Get full text
Journal Article
Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249
Kazda, Christof M, Ding, Ying, Kelly, Ronan P, Garhyan, Parag, Shi, Chunxue, Lim, Chay Ngee, Fu, Haoda, Watson, David E, Lewin, Andrew J, Landschulz, William H, Deeg, Mark A, Moller, David E, Hardy, Thomas A
Published in Diabetes care (01.06.2017)
Published in Diabetes care (01.06.2017)
Get full text
Journal Article
Response to Comment on Kazda et al. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249
Kazda, Christof M, Ding, Ying, Kelly, Ronan P, Garhyan, Parag, Shi, Chunxue, Lim, Chay Ngee, Fu, Haoda, Watson, David E, Lewin, Andrew J, Landschulz, William H, Deeg, Mark A, Moller, David E, Hardy, Thomas A
Published in Diabetes care (01.11.2016)
Published in Diabetes care (01.11.2016)
Get full text
Journal Article
Coding variants in PNPLA3 and TM6SF2 are risk factors for hepatic steatosis and elevated serum alanine aminotransferases caused by a glucagon receptor antagonist
Guzman, Cristina B., Duvvuru, Suman, Akkari, Anthony, Bhatnagar, Pallav, Battioui, Chakib, Foster, Wendra, Zhang, Xiaotian Michelle, Shankar, Sudha S., Deeg, Mark A., Chalasani, Naga, Hardy, Thomas A., Kazda, Christof M., Pillai, Sreekumar G.
Published in Hepatology communications (01.05.2018)
Published in Hepatology communications (01.05.2018)
Get full text
Journal Article
Ultra-rapid Lispro (URLi) Shows Faster Absorption of Insulin Lispro vs. Humalog® during Insulin Pump (CSII) Use in Patients with T1D
KAZDA, CHRISTOF M., LEOHR, JENNIFER, LIU, RONG, HARDY, THOMAS, REDDY, SHOBHA, CHUA, SHANE P.C., GUO, XIAONAN, HOVELMANN, ULRIKE, KAPITZA, CHRISTOPH
Published in Diabetes (New York, N.Y.) (01.07.2018)
Published in Diabetes (New York, N.Y.) (01.07.2018)
Get full text
Journal Article
Ultra-rapid Lispro (URLi) Reduces Postprandial Glucose Excursions vs. Humalog® in Patients with T2D at Multiple Meal-to-Dose Timing Intervals
KAPITZA, CHRISTOPH, LEOHR, JENNIFER, LIU, RONG, REDDY, SHOBHA, DELLVA, MARY A., MATZOPOULOS, MARK, KNADLER, MARY P., MEI, TENG LOH, HARDY, THOMAS, KAZDA, CHRISTOF M.
Published in Diabetes (New York, N.Y.) (01.07.2018)
Published in Diabetes (New York, N.Y.) (01.07.2018)
Get full text
Journal Article
Ultra-rapid Lispro (URLi) Reduces Postprandial Glucose Excursions vs. Humalog® in Patients with T1D at Multiple Meal-to-Dose Timing Intervals
PLUM-MOERSCHEL, LEONA, LEOHR, JENNIFER, LIU, RONG, REDDY, SHOBHA, DELLVA, MARY A., LIM, SHUFEN, MEI, TENG LOH, KNADLER, MARY P., HARDY, THOMAS, KAZDA, CHRISTOF M.
Published in Diabetes (New York, N.Y.) (01.07.2018)
Published in Diabetes (New York, N.Y.) (01.07.2018)
Get full text
Journal Article